1,2,4-Triazolo[1,5-a][1,3,5]triazines (5-Azapurines): Synthesis and Biological Activity

Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors

E. Ongini, Silvio Dionisotti, Stefania Gessi et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1999 · 185 citations · Full text

Molecular Pharmacology, Signal Transduction, Molecular Physiology +13

Purine analog inhibitors of xanthine oxidase ‐ structure activity relationships and proposed binding of the molybdenum cofactor

Roland K. Robins, Ganapathi R. Revankar, Darrell E. O'Brien et al. · Journal of Heterocyclic Chemistry · 1985 · 104 citations

New Phenyl, Molybdenum Cofactor, Pharmacotherapy +16

Convenient Synthesis of Fused Heterocyclic 1,3,5‐Triazines from Some <i>N</i>‐Acyl Imidates and Heterocyclic Amines as Anticancer and Antioxidant Agents

Olcay Bekircan, Murat Küxük, Bahittin Kahveci et al. · Archiv der Pharmazie · 2005 · 85 citations · Full text

In vivo characterisation of ZM 241385, a selective adenosine A2A receptor antagonist

J R Keddie, Simon M. Poucher, G R Shaw et al. · European Journal of Pharmacology · 1996 · 69 citations

Molecular Pharmacology, Signal Transduction, Biochemistry +12

An investigation of the minimal structural conditions lor the dirnroth‐type rearrangement in the polyazaindolizine series

P. GUERRET, Robert Jacquier, Georges Maury · Journal of Heterocyclic Chemistry · 1971 · 59 citations

Rearrangement Rates, Engineering, Heterocyclic +14